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1. Introduction 
We have reported the alignment of all the cyanogen 
bromide fragments (FI-FVII) of human lactotrans- 
ferrin also called lactoferrin [ 1 ], which is a glycopro- 
tein of ~80 000 M r consisting of a single polypeptide 
chain to which 2 carbohydrate groups are attached 
[2]. We characterized N- and C-terminal domains and 
described 70% of the sequence [ 1 ]. The C-terminal 
cyanogen bromide fragment of lactotransferrin, called 
FIII [1], was claimed to be constituted by 111 -+ 16 
amino acids with an M r of 12 700 -- 1900, but so far it 
has not yet been studied in detail. Once more only 
the elucidation of the sequence was able to indicate 
the exact relative molecular mass. The establishment 
of the primary structure of Fill and the prediction 
of its secondary structure reported in this note allowed 
a new series of comparisons with human serum trans- 
ferrin [3,4] and hen ovotransferrin [5] including the 
situation of possible glycosylation sites. 
2. Materials and methods 
Sephadex G-25 fine and G-50 fine were obtained 
from Pharmacia. Trypsin (twice crystallized) was pur- 
chased from Worthington, the Staphylococcus aureus 
Vs protease from Miles, the mouse submaxillary gland 
protease from Boehringer and citraconic anhydride 
from Sigma. All reagents (analytical grade) were pur- 
chased from Prolabo or Merck, except those mployed 
for the sequencer which were obtained from Pierce 
or SDS (Marseilles). 
Human lactotransferrin was obtained according to 
[6]. CNBr cleavage was done as in [7]. The CNBr- 
treated apolactotransferrin was reduced as in [8] and 
alkylated with iodoacetamide. CNBr fragment Fill 
was purified as in [1,9]. 
Partial acid hydrolysis was carried out in 0.03 M 
HC1 during 2 h at 1 IO°C [10]. Citraconylation [11] 
and tryptic digestion (6 h) were performed according 
to [ 1 ]. Digestion by Staphylococcus aureus Va pro- 
tease (18 h) [12] or by mouse submaxillary gland 
protease (2 h) [13] were achieved at 37°C in 0.05 M 
ammonium bicarbonate (pH 8) with an enzyme:sub- 
strate ratio of 1:50. 
The methods used for the purification of the pep- 
tides, for their analysis, their automated degradation 
in a Beckman Sequencer 890 C and their digestion by 
carboxypeptidases A and B (5 min) have been described 
[1 ]. The reported secondary structure was predicted 
as in [14]. 
3. Results 
The sequence of the C-terminal CNBr fragment 
Fill of human lactotransferrin (residues 1-88; fig. 1) 
was established according to the following strategy: 
(a) Determination f a long N-terminal sequence by 
automated Edman degradation (41 amino acids); 
(b) Isolation of tryptic peptides after citraconylation; 
(c) Alignment of the latter by studying peptides 
obtained by partial acid hydrolysis or by digestion 
withStaphylococcusaureus Vs protease or mouse 
submaxillary gland protease; 
(d) Digestion by carboxypeptidases A and B. 
3.1. N-terminal sequence 
A long N-terminal sequence (residues 1-41) was 
determined by automated Edman degradation [ 1,15] 
(fig.l). The amino acid located at position 32 was 
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Fig.1. The amino acid sequence ofthe C-terminal CNBr fragment Fill of human lactotransferrin (LTF) (residues 1-88). Compari- 
son with the homologous C-terminal sequences of human serum transferrin [3] (STF) and hen ovotransferrin [5] (OTF) (residues 
599-686). The sequences preceding the C-terminal fragments are also indicated: (-,) amino acid determined by automated Edman 
degradation; (,-) amino acid determined by carboxypeptidase digestion; (CT) tryptic peptides from citraconylated fragment Fill; 
(T) tryptic peptides; (A) peptides obtained after partial acid hydrolysis; (S and SP) peptides obtained by digestion with Staphylo- 
coccus aureus V 8 protease or mouse submaxillary gland protease, respectively; (I~ / carbohydrate carrying asparagine residue. 
. . . . .  r--- ] \ ,1  The homologous residues 0dentlcal residues, ~---]; conservative changes,[., j ) are boxed; (®) deletion. 
identified in another series of experiments ( ee sec- 
tion 3.3). 
3.2. Tryptic digestion of citraconylated fragment Fil l  
After f'dtration of the tryptic digest on Sephadex 
G-25, 5 fragments were characterized: CT1 (residues 
50-87); CT2 (residues 20-49), CT3 (residues 6-19);  
CT4 (residues 1-5); and CT5 (Lys) (fig.l). The Arg- 
Lys bond (72-73) was not cleaved probably because 
of the citraconylated lysine residue. Two fragments, 
CTI and CT2, were studied. A long N-terminal 
sequence of CT1 (residues 50-73) was determined 
with the sequencer (fig.l). The presence of an Asn- 
Gly sequence at the N-terminal end of fragment CT2 
avoided its automated degradation. A similar observa- 
tion was reported in [16]. An asparaginylglycine 
sequence undergoes cyclization in an acid medium 
[17] and the resulting cyclic imide is not susceptible 
to Edman degradation. After decitraconylation, frag- 
ment CT2 was submitted to tryptic digestion. Only 2 
peptides were obtained, CT2T1 (residues 37-49) and 
CT2T2 (residues 20-36). Cleavage of the Lys-Phe 
(residues 27-28) bond was not observed, and we sug- 
gest that the presence of residues 25 and 26 (Pro and 
Asp) prevent the action of trypsin. The sequence of 
peptide CT2T1 was automatically determined (fig.l). 
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3.3. Partial acid hydrolysis of fragment Fill 
After partial acid hydrolysis of fragment Fill, 3 
peptides were characterized on Sephadex G-25:A1 
(residues 43-88); A2 (residues 2-25); and A3 (resi- 
dues 27-41). The presence of an Asn-Thr sequence 
at the N-terminal end of fragment A1 did not allow 
its automated degradation. To determine its primary 
structure, peptide A1 was digested by Staphylococcus 
aureus Vs protease. After filtration on Sephadex 
G-25, 5 peptides were characterized: A1S1 (residues 
58-81), A1 $2 (residues 46-57), A1S3 (residues 
85-88), A1 $4 (residues 43-45) and A1 $5 (residues 
82-84). Peptide A1 $2 allowed to determine the 
overlapping sequence between peptides CT2T1 and 
CT1 (fig.l). Peptide A3 was submitted to automated 
Edman degradation i  order to determine the residue 
located at position 32 (glutamine) (fig.l). 
3.4. Digestion of fragment FIII by mouse submaxillary 
gland protease 
Following digestion of fragment Fill the cleavage 
of a unique Arg-X bond was observed (Arg 72-Lys 
73). After chromatography on Sephadex G-50, auto- 
mated Edman degradation of the shorter peptide SP2 
(residues 73-88) allowed to complete the sequence 
(residues 73-87) of fragment Fill and to join peptides 
A1S5 and A1S3. 
3.5. Digestion of fragment Fill by carboxypeptidases 
A and B 




amino acids (yields % between parentheses): Phe (39), 
Leu (50), Arg (57), Lys (64). The sequence of frag- 
ment Fill was thus established. 
3.6. Predicted secondary structure 
The C-terminal sequence of lactotransferrin is 
composed of CNBr fragments FII -+ FVI ~ Fill [ 1 ]. 
The results reported in this note allowed to predict 
the secondary structure of a large C-terminal fragment 
(103 amino acids) with its a-helixes, fl-sheets and 
/~-turns (fig.2). 
4. Discussion 
The comparison of the C-terminal sequence of 
lactotransferrin with those of serum and ovotransfer- 
rins allowed to establish remarkable sequence homol- 
ogies (64% and 42%, respectively). The secondary 
structures of the C-terminal fragments of the 3 trans- 
ferrins were also closely homologous with their cystine 
residues in register (residues 584,643,671 and 680; 
see rigA) (fig.2). 
Asparagine residue 20 of fragment Fill belongs to 
a code sequence N G S and is situated in a/~-turn 
(fig.1,2); nevertheless it is not glycosylated. The same 
absence of glycosylation occurs in the homologous 
ovotransferrin sequence whereas in the corresponding 
serum transferrin sequence the asparagine residue 
carries a sugar group. 
Finally an unusually high occurrence of paired 
amino acids in fragment Fill should be mentioned. 
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Fig.2. Predicted secondary structures of the C-terminal moieties of human lactotransferrin (LTF), serum transferrin (STF) and 
ovotxansferrin (OTF). Residues are represented in their respective conformational state: helical ( ~x )' #-sheet ( A ), section which 
has the potentiality o adopt either an a-helical or a #-sheet structure (~) ,  coil (-) ,  #-turn ( -J-q_ ). ( ? ) Carbohydrate car- 
r - ' - " r  
rying asparagine r sidue (N). The identical structures are boxed (comparison LTF-STF[ . . . .  !; comparison LTF-STF-OTF 
~- -~) .  numbering of the residues of OTF and LTF, see fig.1. For the 
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